Investigation of antidepressant medication usage after bariatric surgery

Obesity Surgery

Volumn 22, Issue 4, 2012, Pages 530-535

  Cunningham, Julie L ^a   Merrell, Cory C ^a   Sarr, Michael ^a   Somers, Kristin J ^a   McAlpine, Donald ^a   Reese, Michael ^a   Stevens, Susanna R ^a   Clark, Matthew M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Antidepressant medications; Bariatric surgery; Depression; Weight loss

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; FLUOXETINE;

ADULT; AGED; ARTICLE; BARIATRIC SURGERY; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL RECORD REVIEW; MOOD DISORDER; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; WEIGHT REDUCTION; ADOLESCENT; COMORBIDITY; DEPRESSION; FOLLOW UP; MIDDLE AGED; MORBID OBESITY; PRESCRIPTION; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; STATISTICS; STOMACH BYPASS; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; COMORBIDITY; DEPRESSION; DRUG PRESCRIPTIONS; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; OBESITY, MORBID; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84861809673     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-011-0517-8     Document Type: Article

References (34)

1. Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;294:1909-17. (Pubitemid 41464692)
2. American Society for Bariatric Surgery. Fact sheet. http://www.asbs.org/ Newsite07/media/asmbs-fs-surgery.pdf. Accessed December 27, 2010.
3. Collazo-Clavell ML, Clark MM, McAlpine DE, et al. Assessment and preparation of patients for bariatric surgery. Mayo Clin Proc. 2006;81:S11-7. (Pubitemid 44484961)
4. Halmi A. KA, Long M, Stunkard AJ et al. Psychiatric diagnosis of morbidly obese gastric bypass patients. Am J Psychiatry. 1980;137:470-2.
5. Black DW, Goldstein RB, Mason EE. Prevalence of mental disorder in 88 morbidly obese bariatric clinic patients. Am J Psychiatry. 1992;149:227-34.
6. Rosik CH. Psychiatric symptoms among prospective bariatric surgery patients: rates of prevalence and their relation to social desirability, pursuit of surgery, and follow-up attendance. Obes Surg. 2005;15:677-83. (Pubitemid 40851997)
7. Sarwer DB, Cohn NI, Gibbons LM, et al. Psychiatric diagnoses and psychiatric treatment among bariatric surgery candidates. Obes Surg. 2004;14:1148-56. (Pubitemid 39458586)
8. Powers PS, Rosemurgy A, Boyd F, et al. Outcome of gastric restriction procedures: weight, psychiatric diagnoses, and satisfaction. Obes Surg. 1997;7:471-7. (Pubitemid 28039436)
9. Clark MM, Niaura R, King TK, et al. Depression, smoking, activity level, and health status: pretreatment predictors of attrition in obesity treatment. Addict Behav. 1996;21:509-13. (Pubitemid 26194610)
10. Segal JB, Clark JM, Shore AD, et al. Prompt reduction in use of medications for comorbid conditions after bariatric surgery. Obes Surg. 2009;19:1646-56.
11. Wadden TA, Sarwer DB, Womble LG, et al. Psychosocial aspects of obesity and obesity surgery. Surg Clin North Am. 2001;81:1001-24. (Pubitemid 32895997)
12. Batsis JA, Lopez-Jimenez F, Collazo-Clavell ML et al. Quality of life after bariatric surgery. Am J Med. 2009;122: 1055.e1-10.
13. Zwaan M, Enderle J, Wagner S et al. Anxiety and depression in bariatric surgery patients: a prospective, follow-up study using structured clinical interviews. J Affect Disord 2011; in press.
14. Hayden MJ, Dixon JB, Dixon ME, et al. Characterization of the improvement in depressive symptoms following bariatric surgery. Obes Surg. 2011;21:328-35.
15. Assimakopoulos K, Karaivazoglou K, Panayiotopoulos S, et al. Bariatric surgery is associated with reduced depressive symptoms and better sexual function in obese female patients: a one-year follow-up study. Obes Surg. 2011;21:362-66.
16. Clark MM, Hanna BK, Mai JL, et al. Sexual abuse survivors and psychiatric hospitalization after bariatric surgery. Obes Surg. 2007;17:465-9. (Pubitemid 46850186)
17. Potteiger CE, Paragi PR, Inverso NA, et al. Bariatric surgery: shedding the monetary weight of prescription costs in the managed care area. Obes Surg. 2004;14:725-30. (Pubitemid 38982253)
18. Batsis JA, Romero-Corral A, Collazo-Clavell ML, et al. Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc. 2008;83:897-907.
19. Kendrick ML, Clark MM, Collazo-Clavell MD, et al. The multidisciplinary team in a bariatric surgery program. In: Buchwald H, Cowan Jr GSM, Pories WJ, editors. Surgical Management of Obesity. Philadelphia: Elsevier Science; 2006. p. 425-31.
20. Krukowski RA, Friedman KE, Applegate KL. The utility of the Beck Depression Inventory in a bariatric surgery population. Obes Surg. 2010;20:426-31.
21. Hayden MJ, Dixon JB, Dixon ME, et al. Confirmatory factor analysis of the Beck Depression Inventory in obese individuals seeking surgery. Obes Surg. 2010;20:432-39.
22. Demyttenaere K, Jaspers L. Bupropion and SSRI-induced side effects. J Psychopharmacol. 2008;22:792-804.
23. Sussman N, Ginsberg DL, Bikoff J. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials. J Clin Psychiatry. 2001;62:256-60. (Pubitemid 32428764)
24. Aronne LJ, Segal KR. Weight gain in the treatment of mood disorders. J Clin Psychiatry. 2003;64:22-9. (Pubitemid 36903904)
25. Schwartz TL, Nihalani N, Jindal S, et al. Psychiatric medicationinduced obesity: a review. Obes Rev. 2004;5:115-21.
26. Schwartz TL, Nihalani N, Virk S, et al. Psychiatric medicationinduced obesity: treatment options. Obes Rev. 2004;5:233-8. (Pubitemid 39423003)
27. Vanina Y, Podolskaya A, Sedky K, et al. Body weight changes associated with psychopharmacology. Psychiatr Serv. 2002;53:842-7. (Pubitemid 34742766)
28. Virk S, Schwartz TL, Jindal S, et al. Psychiatric medication induced obesity: an aetiologic review. Obes Rev. 2004;5:167-70. (Pubitemid 38998241)
29. Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev. 2010;11:41-50.
30. Seaman JS, Bowers SP, Dixon MS, et al. Dissolution of common psychiatric medications in a Roux-en-Y gastric bypass model. Psychosomatics. 2005;46:250-3. (Pubitemid 40594315)
31. Sarwer DB, Faulconbridge LF, Steffen KF, et al. Changes in the gastrointestinal tract and body weight can alter drug absorption. Current Psych. 2011;10:19-29.
32. McAlpine DE. How to adjust drug dosing after bariatric surgery. Current Psych. 2006;5:27-8.
33. Miller AD, Smith KM. Medication and nutrient administration considerations after bariatric surgery. Am J Health Syst Pharm. 2006;63:1852-7. (Pubitemid 44477456)
34. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000;157:1-45.